Literature DB >> 33663644

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.

Alexandre Gaymard1,2,3, Paolo Bosetti3,4, Adeline Feri3,5, Gregory Destras1,2, Vincent Enouf6, Alessio Andronico4, Sonia Burrel7, Sylvie Behillil6, Claire Sauvage5, Antonin Bal1,2, Florence Morfin1,2, Sylvie Van Der Werf6, Laurence Josset1,2, François Blanquart8,9, Bruno Coignard10,5, Simon Cauchemez10,4, Bruno Lina1,10,2.   

Abstract

The emergence of SARS-CoV-2 variant 20I/501Y.V1 (VOC-202012/1 or GR/501Y.V1) is concerning given its increased transmissibility. We reanalysed 11,916 PCR-positive tests (41% of all positive tests) performed on 7-8 January 2021 in France. The prevalence of 20I/501Y.V1 was 3.3% among positive tests nationwide and 6.9% in the Paris region. Analysing the recent rise in the prevalence of 20I/501Y.V1, we estimate that, in the French context, 20I/501Y.V1 is 52-69% more transmissible than the previously circulating lineages, depending on modelling assumptions.

Entities:  

Keywords:  20I/501Y.V1; COVID; France; SARS-CoV-2; mutation; surveillance; viral infections

Mesh：

Year:  2021        PMID： 33663644      PMCID： PMC7934223          DOI： 10.2807/1560-7917.ES.2021.26.9.2100133

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  1 in total

1.  Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.

Authors:  Antonin Bal; Gregory Destras; Alexandre Gaymard; Karl Stefic; Julien Marlet; Sébastien Eymieux; Hadrien Regue; Quentin Semanas; Constance d'Aubarede; Geneviève Billaud; Frédéric Laurent; Claudia Gonzalez; Yahia Mekki; Martine Valette; Maude Bouscambert; Catherine Gaudy-Graffin; Bruno Lina; Florence Morfin; Laurence Josset
Journal:  Euro Surveill       Date:  2021-01
  1 in total
  30 in total

1.  Back to the Roots: A Discrete Kermack-McKendrick Model Adapted to Covid-19.

Authors:  Matthias Kreck; Erhard Scholz
Journal:  Bull Math Biol       Date:  2022-02-17       Impact factor: 1.758

2.  Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China.

Authors:  Hengcong Liu; Juanjuan Zhang; Wenhong Zhang; Marco Ajelli; Hongjie Yu; Jun Cai; Xiaowei Deng; Cheng Peng; Xinghui Chen; Juan Yang; Qianhui Wu; Xinhua Chen; Zhiyuan Chen; Wen Zheng; Cécile Viboud
Journal:  BMC Med       Date:  2022-01-31       Impact factor: 8.775

3.  Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation.

Authors:  Huanyu Wang; Sophonie Jean; Richard Eltringham; John Madison; Pamela Snyder; Huolin Tu; Daniel M Jones; Amy L Leber
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

4.  Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France.

Authors:  Laura Di Domenico; Chiara E Sabbatini; Giulia Pullano; Daniel Lévy-Bruhl; Vittoria Colizza
Journal:  Euro Surveill       Date:  2021-04

5.  Controlling healthcare-associated transmission of SARS-CoV-2 variant of concern 202012/01 in a large hospital network.

Authors:  C Duverger; V Souyri; C Monteil; S Fournier
Journal:  J Hosp Infect       Date:  2021-05-07       Impact factor: 3.926

6.  Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study.

Authors:  Cécile Tran Kiem; Pascal Crépey; Paolo Bosetti; Daniel Levy Bruhl; Yazdan Yazdanpanah; Henrik Salje; Pierre-Yves Boëlle; Simon Cauchemez
Journal:  Euro Surveill       Date:  2021-06

7.  The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021.

Authors:  Bénédicte Roquebert; Sabine Trombert-Paolantoni; Stéphanie Haim-Boukobza; Emmanuel Lecorche; Laura Verdurme; Vincent Foulongne; Mircea T Sofonea; Samuel Alizon
Journal:  Euro Surveill       Date:  2021-06

8.  Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021.

Authors:  Samuel Alizon; Stéphanie Haim-Boukobza; Vincent Foulongne; Laura Verdurme; Sabine Trombert-Paolantoni; Emmanuel Lecorche; Bénédicte Roquebert; Mircea T Sofonea
Journal:  Euro Surveill       Date:  2021-07

9.  A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures.

Authors:  Cécile Tran Kiem; Clément R Massonnaud; Daniel Levy-Bruhl; Chiara Poletto; Vittoria Colizza; Paolo Bosetti; Arnaud Fontanet; Amélie Gabet; Valérie Olié; Laura Zanetti; Pierre-Yves Boëlle; Pascal Crépey; Simon Cauchemez
Journal:  EClinicalMedicine       Date:  2021-07-14

10.  Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.

Authors:  Tiffany Charmet; Laura Schaeffer; Rebecca Grant; Simon Galmiche; Olivia Chény; Cassandre Von Platen; Alexandra Maurizot; Alexandra Rogoff; Faïza Omar; Christophe David; Alexandra Septfons; Simon Cauchemez; Alexandre Gaymard; Bruno Lina; Louise H Lefrancois; Vincent Enouf; Sylvie van der Werf; Alexandra Mailles; Daniel Levy-Bruhl; Fabrice Carrat; Arnaud Fontanet
Journal:  Lancet Reg Health Eur       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.